Page:United States Statutes at Large Volume 117.djvu/2335

This page needs to be proofread.

[117 STAT. 2316]
PUBLIC LAW 107-000—MMMM. DD, 2003
[117 STAT. 2316]

117 STAT. 2316 Establishment.

42 USC 1395rr note. Deadline.

VerDate 11-MAY-2000

13:59 Aug 30, 2004

PUBLIC LAW 108–173—DEC. 8, 2003

(A) IN GENERAL.—In carrying out the demonstration under this subsection, the Secretary shall establish an advisory board comprised of representatives described in subparagraph (B) to provide advice and recommendations with respect to the establishment and operation of such demonstration. (B) REPRESENTATIVES.—Representatives referred to in subparagraph (A) include representatives of the following: (i) Patient organizations. (ii) Individuals with expertise in end stage renal dialysis services, such as clinicians, economists, and researchers. (iii) The Medicare Payment Advisory Commission, established under section 1805 of the Social Security Act (42 U.S.C. 1395b–6). (iv) The National Institutes of Health. (v) Network organizations under section 1881(c) of the Social Security Act (42 U.S.C. 1395rr(c)). (vi) Medicare contractors to monitor quality of care. (vii) Providers of services and renal dialysis facilities furnishing end stage renal disease services. (C) TERMINATION OF ADVISORY PANEL.—The advisory panel shall terminate on December 31, 2008. (6) AUTHORIZATION OF APPROPRIATIONS.—There are authorized to be appropriated, in appropriate part from the Federal Hospital Insurance Trust Fund and the Federal Supplementary Medical Insurance Trust Fund, $5,000,000 in fiscal year 2006 to conduct the demonstration under this subsection. (f) REPORT ON A BUNDLED PROSPECTIVE PAYMENT SYSTEM FOR END STAGE RENAL DISEASE SERVICES.— (1) REPORT.— (A) IN GENERAL.—Not later than October 1, 2005, the Secretary shall submit to Congress a report detailing the elements and features for the design and implementation of a bundled prospective payment system for services furnished by end stage renal disease facilities including, to the maximum extent feasible, bundling of drugs, clinical laboratory tests, and other items that are separately billed by such facilities. The report shall include a description of the methodology to be used for the establishment of payment rates, including components of the new system described in paragraph (2). (B) RECOMMENDATIONS.—The Secretary shall include in such report recommendations on elements, features, and methodology for a bundled prospective payment system or other issues related to such system as the Secretary determines to be appropriate. (2) ELEMENTS AND FEATURES OF A BUNDLED PROSPECTIVE PAYMENT SYSTEM.—The report required under paragraph (1) shall include the following elements and features of a bundled prospective payment system: (A) BUNDLE OF ITEMS AND SERVICES.—A description of the bundle of items and services to be included under the prospective payment system. (B) CASE MIX.—A description of the case-mix adjustment to account for the relative resource use of different types of patients.

Jkt 019194

PO 00000

Frm 00252

Fmt 6580

Sfmt 6581

D:\STATUTES\2003\19194PT3.001

APPS10

PsN: 19194PT3